Pacira Biosciences Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$22.65

+0.54 (+2.44%)

As of Mar 23, 10:03 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target +0.3% upside

Low Target $15.64

Average Target $22.71

High Target $35.67

Current Price $22.65

Current
$22.65

Target
$22.71

$15.64 $22.71 avg $35.67

Scenario Analysis

Bear Case

$15.64

-30.9%

Low target

Base Case

$22.71

+0.3%

Avg target

Bull Case

$35.67

+57.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$27.64

-18.1% from high

52-Week Low

$18.80

+20.5% from low

Target vs 52W High

$22.71

-17.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%